Ideal cardiovascular health and cognitive aging in the Northern Manhattan

Journal of the American Heart Association

Volumn 5, Issue 3, 2015, Pages

  Gardener, Hannah ^a   Wright, Clinton B ^a   Dong, Chuanhui ^a   Cheung, Ken ^b   DeRosa, Janet ^c   Nannery, Micaela ^a   Stern, Yaakov ^c   Elkind, Mitchell S V ^b,c   Sacco, Ralph L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c NONE   (United States)

Author keywords

Blood pressure; Epidemiology; Glucose; Risk factors; Smoking

Indexed keywords

CHOLESTEROL; GLUCOSE;

AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; BRAIN FUNCTION; CARDIOVASCULAR RISK; CAUCASIAN; COGNITIVE AGING; DIET; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; HISPANIC; HUMAN; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NEW YORK; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROCESSING SPEED; SEMANTIC MEMORY; SMOKING; AGE; AGING; CARDIOVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; ETHNOLOGY; HEALTH STATUS; MEMORY; MIDDLE AGED; PROSPECTIVE STUDY; PROTECTION; PSYCHOLOGY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TIME FACTOR; VERY ELDERLY;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; COGNITION; COGNITION DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXECUTIVE FUNCTION; FEMALE; HEALTH STATUS; HISPANIC AMERICANS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NEW YORK CITY; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TIME FACTORS;

EID: 84991520258     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002731     Document Type: Article

References (36)

1. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586-613.
2. Kulshreshtha A, Vaccarino V, Judd SE, Howard VJ, McClellan WM, Muntner P, Hong Y, Safford MM, Goyal A, Cushman M. Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013;44:1909-1914.
3. Dong C, Rundek T, Wright CB, Anwar Z, Elkind MS, Sacco RL. Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across Whites, Blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2012;125:2975-2984.
4. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166:367-378.
5. Parrott MD, Greenwood CE. Dietary influences on cognitive function with aging: from high-fat diets to healthful eating. Ann N Y Acad Sci. 2007;1114:389-397.
6. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58:498-504.
7. Wolf PA, Beiser A, Elias MF, Au R, Vasan RS, Seshadri S. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res. 2007;4:111-116.
8. Hassing LB, Hofer SM, Nilsson SE, Berg S, Pedersen NL, McClearn G, Johansson B. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing. 2004;33:355-361.
9. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42-48.
10. Goldstein FC, Ashley AV, Endeshaw YW, Hanfelt J, Lah JJ, Levey AI. Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2008;22:336-342.
11. Nooyens AC, van Gelder BM, Verschuren WM. Smoking and cognitive decline among middle-aged men and women: the Doetinchem Cohort Study. Am J Public Health. 2008;98:2244-2250.
12. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661-666.
13. Committee on the Public Health Dimensions of Cognitive Aging, Board on Health Sciences Policy, Institute of Medicine. Cognitive aging: progress in understanding and opportunities for action. The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press (US). 2015.
14. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke. 2004;35:2263-2269.
15. Wallman KK, Hodgdon J. Race and ethnic standards for Federal statistics and administrative reporting. Stat Report. 1977;450-454.
16. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA. 1999;281:53-60.
17. Kargman DE, Sacco RL, Boden-Albala B, Paik MC, Hauser WA, Shea S. Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology. 1999;18:174-184.
18. Willey JZ, Moon YP, Paik MC, Boden-Albala B, Sacco RL, Elkind MS. Physical activity and risk of ischemic stroke in the Northern Manhattan Study. Neurology. 2009;73:1774-1779.
19. Gardener H, Della Morte D, Elkind MS, Sacco RL, Rundek T. Lipids and carotid plaque in the Northern Manhattan Study (NOMAS). BMC Cardiovasc Disord. 2009;9:55.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
21. Marquine MJ, Attix DK, Goldstein LB, Samsa GP, Payne ME, Chelune GJ, Steffens DC. Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression. Stroke. 2010;41:1946-1950.
22. Siedlecki KL, Rundek T, Elkind MS, Sacco RL, Stern Y, Wright CB. Using contextual analyses to examine the meaning of neuropsychological variables across samples of English-speaking and Spanish-speaking older adults. J Int Neuropsychol Soc. 2012;18:223-233.
23. Berry DC, Banbury S, Henry L. Transfer across form and modality in implicit and explicit memory. Q J Exp Psychol A. 1997;50:1-24.
24. Duff K. Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods. Arch Clin Neuropsychol. 2012;27:248-261.
25. Wright CB, Paik MC, Brown TR, Stabler SP, Allen RH, Sacco RL, DeCarli C. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke. 2005;36:1207-1211.
26. Gambhir IS, Khurana V, Kishore D, Sinha AK, Mohapatra SC. A clinicoepidemiological study of cognitive function status of community-dwelling elderly. Indian J Psychiatry. 2014;56:365-370.
27. Reis JP, Loria CM, Launer LJ, Sidney S, Liu K, Jacobs DR Jr, Zhu N, Lloyd-Jones DM, He K, Yaffe K. Cardiovascular health through young adulthood and cognitive functioning in midlife. Ann Neurol. 2013;73:170-179.
28. Crichton GE, Elias MF, Davey A, Alkerwi A. Cardiovascular health and cognitive function: the Maine-Syracuse Longitudinal Study. PLoS One. 2014;9:e89317.
29. Thacker EL, Gillett SR, Wadley VG, Unverzagt FW, Judd SE, McClure LA, Howard VJ, Cushman M. The American Heart Association Life's Simple 7 and incident cognitive impairment: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc. 2014;3:e000635 doi: 10.1161/JAHA.113.000635.
30. Nishtala A, Preis SR, Beiser A, Devine S, Hankee L, Seshadri S, Wolf PA, Au R. Midlife cardiovascular risk impacts executive function: Framingham Offspring Study. Alzheimer Dis Assoc Disord. 2014;28:16-22.
31. Unverzagt FW, McClure LA, Wadley VG, Jenny NS, Go RC, Cushman M, Kissela BM, Kelley BJ, Kennedy R, Moy CS, Howard V, Howard G. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology. 2011;77:1729-1736.
32. Joosten H, van Eersel ME, Gansevoort RT, Bilo HJ, Slaets JP, Izaks GJ. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke. 2013;44:1543-1549.
33. Kaffashian S, Dugravot A, Elbaz A, Shipley MJ, Sabia S, Kivimaki M, Singh-Manoux A. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology. 2013;80:1300-1306.
34. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61:1531-1534.
35. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
36. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015-1022.